Healthcare Services

Global Multiplex Assays Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Multiplex Assays Market Expected To Change Between 2026 And 2030?

The market size for multiplex assays has shown robust growth over recent years. It is projected to expand from $3.88 billion in 2025 to $4.21 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. The historical growth can be attributed to several factors such as the increasing use of molecular diagnostics, the rising demand for PCR-based testing, the expansion of research endeavors, elevated needs for pathogen identification, and the initial uptake of multiplex protein assays.

The market for multiplex assays is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $5.75 billion, growing at a compound annual growth rate (CAGR) of 8.1%. This expansion during the projection period stems from several factors, including progress in multiplex technologies, a surge in the adoption of clinical diagnostics, wider applications in precision medicine, increased utilization in forensic laboratories, and a rising need for genetic mutation analysis. Key developments anticipated during this period encompass the increased uptake of multiplex PCR for identifying pathogens, greater deployment of multiplex assays in mutation and gene analysis, an escalating requirement for high-throughput protein quantification, the broadening of multiplex platforms within clinical diagnostics, and the enhanced employment of multiplex assays in forensic and research investigations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

Which Major Factors Are Driving The Expansion Of The Multiplex Assays Market?

The rising prevalence of chronic diseases is projected to propel the expansion of the global multiplex assay market in the future. These persistent health conditions develop gradually, often necessitating continuous care and impacting various bodily systems and an individual’s general well-being. A significant contributor to the increasing incidence of chronic diseases is the elderly demographic, as older age increases physical susceptibility, diminishes the body’s ability to heal, and prolongs exposure to various risk elements, rendering individuals more prone to developing and worsening long-term health conditions. Multiplex assays allow for concurrent analysis of multiple biomarkers, facilitating prompt identification, more accurate tracking of conditions, and enhanced medical choices for patients dealing with chronic conditions. For instance, in April 2024, according to Allergy UK, a UK-based national charity, over 21 million people in the UK suffer from allergies, which was the most frequently reported chronic health condition in 2022, and forecasts suggest that by 2026, half of Europe’s population will encounter at least one allergic reaction. Consequently, the rising occurrence of chronic diseases is propelling the multiplex assay market.

How Is The Multiplex Assays Market Structured Across Different Segments?

The multiplex assays market covered in this report is segmented –

1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types

2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies

3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies

4) By Application: Research And Development, Clinical Diagnostics

5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Subsegments:

1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay), Luminex xMAP Technology, Western Blotting, Immunohistochemistry, Mass Spectrometry-Based Assays

2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction), qPCR (Quantitative PCR), NGS (Next-Generation Sequencing), Microarray Analysis, RT-PCR (Reverse Transcription PCR)

3) By Other Types: Cell-Based Multiplex Assays, Bioanalytical Assays, Imaging-Based Assays, Surface Plasmon Resonance (SPR) Assays

What Trends Are Affecting The Expansion Of The Multiplex Assays Market?

Leading companies within the multiplex assays market are concentrating on developing innovative advancements, such as ultrasensitive multiplexed digital PCR assays, with the goal of enhancing mutation detection accuracy and supporting more efficient clinical research workflows. These ultrasensitive multiplexed digital PCR assays are high-precision analytical tools designed to detect and quantify multiple low-abundance genetic variants in a single reaction, thereby boosting sensitivity while simultaneously reducing sample consumption and overall testing time. For instance, in January 2024, Bio-Rad Laboratories Inc., a US-based life science research and clinical diagnostic products company, launched the ddPLEX ESR1 Mutation Detection Kit. This kit stands as the first ultrasensitive multiplexed digital PCR assay specifically created for identifying breast cancer mutations in clinical research. The assay facilitates the simultaneous detection and quantification of seven known relevant ESR1 mutations within a single well, thereby streamlining the testing process. It exhibits an analytical sensitivity reaching as low as 0.01% variant allele fraction (VAF), enabling the identification of low-frequency mutations that could be vital in cancer diagnostics. Furthermore, the kit can be utilized with circulating tumor DNA (ctDNA) from plasma or DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissue samples, offering flexibility in the types of samples used for testing.

Which Major Players Dominate The Multiplex Assays Market?

Major companies operating in the multiplex assays market are Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

Read the full multiplex assays market report here:

https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Which Region Currently Holds The Largest Share Of The Multiplex Assays Market?

North America was the largest region in the multiplex assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Multiplex Assays Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5775&type=smp

Browse Through More Reports Similar to the Global Multiplex Assays Market 2026, By The Business Research Company

Multiple Myeloma Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/multiple-myeloma-drugs-global-market-report

Myelodysplastic Syndrome Global Market Report

https://www.thebusinessresearchcompany.com/report/myelodysplastic-syndrome-global-market-report

Chronic Myeloid Leukemia Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795